Request UreaAide™ Samples
UreaAide™ is the lower cost, better tasting Urea for Hyponatremia
We offer 3 great UreaAide options. Our lower cost premium 15 gram sparkling orange packets, UreaAide 2.5 gram tasteless UreaTabs and USP grade Unflavored/Self flavored Urea. Patient savings of up to 60%. UreaAide™ is made in the USA, in an FDA registered cGMP facility and utilizes only premium USP grade Urea. All UreaAide products undergo 3rd party independent laboratory testing for safety, purity and stability.
Submit Sample Request Here
Thank you for the physician free sample request. We will get it right out to you. If you would like to try the #UreaAide™Challenge tag @KidneyAide on twitter, we can’t wait to see the post.
Our mission is to empower healthcare providers to treat Hyponatremia with a safe reliable product & help our patients get this at a much lower cost while providing more options. We appreciate you considering UreaAide™ for your patients. For questions or feedback, please email us firstname.lastname@example.org. We typically respond within the day.
Dr. Barry Nephrologist & KidneyAide Co-Founder
For pharmacies, hospitals, and healthcare formulary considerations; If you are a McKesson customer you may reach out to your McKesson sales reps, local distribution centers or McKesson customer service department to place orders for UreaAide.
If you are a McKesson customer you may reach out to your McKesson sales reps, local distribution centers or McKesson customer service department to place orders for UreaAide.
UreaAide™ Featured in ASN Kidney News as a novel therapeutic for SIADH
Click here to read the full article.
Dosing of UreaAide™ Urea is based on the European Best Practice Guidelines (see below):
Urea is dosed at 0.25-0.5 grams per kilogram per day usually in divided doses either BID or TID.
Example: 60 KG person would get 30 grams per day in divided doses,1 packet or 1 scoop twice daily.
European renal best practice guidelines for the treatment of SIADH
7.4.3. Patients with SAIDH
220.127.116.11. In moderate or profound hyponatremia, we suggest restricting fluid intake as a first-line-treatment (2D).
18.104.22.168 In moderate or profound hyponatremia, we suggest the following can be considered equal second-line treatments: a) Increasing solute intake with 0.25–0.50g/kg per day if urea or a combination of low dose loop diuretics and oral sodium chloride (2D).
22.214.171.124 In moderate or profound hyponatremia, we recommend against lithium or demeclocycline (1D).
126.96.36.199 In moderate hyponatremia, we do not recommend vasopressin receptor antagonists (1C).
188.8.131.52 In profound hyponatremia, we recommend against vasopressin receptor antagonists (1C).
Insurance Coverage for UreaAide™
UreaAide™ is a qualified medical expense and is thus tax deductible through an HSA, FSA, or HRA.
Insurance carriers will undoubtedly ask for a prior authorization from the physician or medical provider.
The patient should contact their insurance carrier and let them know their provider has recommended UreaAide™.
UreaAide™, if covered, will be covered under Medical Benefit not pharmaceutical benefits or under DME. HCPCS codes B-4155 or the DME code A-9999 are utilized when the PA form is submitted. In practice unfortunately, insurance carriers often will not cover the cost. This is why we offer our Unflavored UreaAide™ urea at modest prices.
Urea Safety in Long Term Use
Urea has been effetively used for Hyponatremia since 1980.
Here a 2012 study compared 12 patients with SIADH given 1 year of treatment with an oral V2 receptor antagonist, then given an 8 day drug holiday and started on Urea for another year of therapy.
The mean age was 73 years.
Mean baseline serum sodium level was 125 meq/L.
After 1 year of Urea therapy the mean serum Sodium was 135 meq/L.
1 patient stopped the Vaptan due to excessive thirst, whereas all patients were able to continue Urea without any significant adverse effects.
Free Downloadable Flyers for Patients & Physicians
Dr. Gorlitsky Chronic Hyponatremia Talk 2021
PowerPoint presentation created by Dr Barry Gorlitsky on evidence based approach to Chronic Hyponatremia. Example case, prevalence, how to make the correct diagnosis of Hyponatremia and SIADH, consequences of under treatment and current treatment options, including Urea.
Click here to download the full presentation in Powerpoint (.pptx) format.